| Outlining cardiac ion channel protein interactors and their signature in the human electrocardiogram S Maurya, RW Mills, K Kahnert, DY Chiang, G Bertoli, PR Lundegaard, ... Nature Cardiovascular Research 2 (7), 673-692, 2023 | 9 | 2023 |
| Cardiac fibroblast sub-types in vitro reflect pathological cardiac remodeling in vivo KM Herum, G Weng, K Kahnert, R Waikel, G Milburn, A Conger, P Anaya, ... Matrix Biology Plus 15, 100113, 2022 | 9 | 2022 |
| Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts A Sorrentino, N Bagwan, N Linscheid, PC Poulsen, K Kahnert, ... Scientific Reports 12 (1), 4760, 2022 | 7 | 2022 |
| Rare and common genetic variation underlying atrial fibrillation risk OB Vad, LM Monfort, C Paludan-Müller, K Kahnert, SZ Diederichsen, ... JAMA cardiology 9 (8), 732-740, 2024 | 5 | 2024 |
| Intrinsic Diversity In Primary Cilia Revealed Through Spatial Proteomics JN Hansen, H Sun, K Kahnert, E Westenius, A Johannesson, K Tzavlaki, ... bioRxiv, 2024.10. 20.619273, 2024 | 4 | 2024 |
| Proteomics couples electrical remodelling to inflammation in a murine model of heart failure with sinus node dysfunction K Kahnert, L Soattin, RW Mills, C Wilson, S Maurya, A Sorrentino, ... Cardiovascular research 120 (8), 927-942, 2024 | 3 | 2024 |
| FLEXIQuant-LF to quantify protein modification extent in label-free proteomics data CN Schlaffner, K Kahnert, J Muntel, R Chauhan, BY Renard, JA Steen, ... Elife 9, e58783, 2020 | 3 | 2020 |
| FLEXIQuant-LF: Robust Regression to Quantify Protein Modification Extent in Label-Free Proteomics Data K Kahnert, CN Schlaffner, J Muntel, R Chauhan, BY Renard, JA Steen, ... bioRxiv, 2020.05. 11.088492, 2020 | 2 | 2020 |
| SubCell: Vision foundation models for microscopy capture single-cell biology A Gupta, Z Wefers, K Kahnert, JN Hansen, WD Leineweber, A Cesnik, ... bioRxiv, 2024.12. 06.627299, 2024 | 1 | 2024 |
| Loss-of-function variants in founder population highlight atrial myopathy as susceptibility to atrial fibrillation C Paludan-Muller, OB Vad, K Kahnert, G Ahlberg, LM Monfort, SA Rand, ... European Heart Journal 43 (Supplement_2), ehac544. 2875, 2022 | 1 | 2022 |
| In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation JS Achter, ET Vega, A Sorrentino, K Kahnert, KD Galsgaard, ... Cardiovascular Diabetology 23 (1), 258, 2024 | | 2024 |
| Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts A Sorrentino, N Bagwan, N Linscheid, P Poulsen, K Kahnert, M Thomsen, ... European Heart Journal 42 (Supplement_1), ehab724. 3294, 2021 | | 2021 |
